"Cyclohexanols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Monohydroxy derivatives of cyclohexanes that contain the general formula R-C6H11O. They have a camphorlike odor and are used in making soaps, insecticides, germicides, dry cleaning, and plasticizers.
| Descriptor ID |
D003511
|
| MeSH Number(s) |
D02.033.415.510.500 D02.455.426.392.368.367.318 D10.289.510.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cyclohexanols".
Below are MeSH descriptors whose meaning is more specific than "Cyclohexanols".
This graph shows the total number of publications written about "Cyclohexanols" by people in this website by year, and whether "Cyclohexanols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclohexanols" by people in Profiles.
-
Kellner CH, Geduldig ET, Knapp RG, Young RC, Weiner RD, Greenberg RM, Prudic J, McCall WV, Petrides G, Husain MM, Rudorfer MV, Lisanby SH. More data on speed of remission with ECT in geriatric depression. Br J Psychiatry. 2015 Feb; 206(2):167.
-
Bisesi JH, Bridges W, Klaine SJ. Effects of the antidepressant venlafaxine on fish brain serotonin and predation behavior. Aquat Toxicol. 2014 Mar; 148:130-8.
-
Loprinzi CL, Levitt R, Barton D, Sloan JA, Dakhil SR, Nikcevich DA, Bearden JD, Mailliard JA, Tschetter LK, Fitch TR, Kugler JW. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7. J Clin Oncol. 2006 Mar 20; 24(9):1409-14.
-
DeVane CL, Donovan JL, Liston HL, Markowitz JS, Cheng KT, Risch SC, Willard L. Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers. J Clin Psychopharmacol. 2004 Feb; 24(1):4-10.
-
DeVane CL. Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea. J Clin Psychiatry. 2003; 64 Suppl 18:14-9.
-
Upadhyaya HP, Brady KT, Sethuraman G, Sonne SC, Malcolm R. Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychopharmacol. 2001 Feb; 21(1):116-8.
-
Ballenger JC. Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder. J Clin Psychiatry. 2001; 62 Suppl 19:11-9.
-
Hamner MB, Frueh BC. Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder. Int Clin Psychopharmacol. 1998 Sep; 13(5):233-4.
-
Ballenger JC. Clinical evaluation of venlafaxine. J Clin Psychopharmacol. 1996 Jun; 16(3 Suppl 2):29S-35S; discussion 35S-36S.
-
Morton WA, Sonne SC, Verga MA. Venlafaxine: a structurally unique and novel antidepressant. Ann Pharmacother. 1995 Apr; 29(4):387-95.